ETH Zurich Breakthrough: Boron-Based "Chemical Glue" Accelerates Protein Synthesis by 1,000x to Unlock New Cancer Immunotherapies

ETH Zurich researchers use boron to speed up protein coupling by 1,000x, enabling the production of clump-prone proteins for targeted cancer therapies.

By: AXL Media

Published: Mar 10, 2026, 4:21 AM EDT

Source: The information in this article was sourced from ETH Zurich

Overcoming the "Clumping" Barrier in Medicine

Modern pharmacology relies heavily on signaling proteins and membrane receptors; in fact, approximately 60% of all current medicines target receptors anchored in cell membranes. However, these vital proteins are notoriously difficult to work with in a laboratory setting because they are poorly soluble. When chemists attempt to produce them synthetically, the proteins often reach a concentration threshold where they "clump" together, losing their biological function and stalling production. This physical limitation has long acted as a bottleneck for cancer research, as just one insoluble segment can block a synthesis robot from completing an entire protein chain.

The Speed of Boron vs. Traditional Carbon Chemistry

The breakthrough at ETH Zurich centers on a fundamental law of chemistry: the slower a reaction occurs, the higher the concentration of substances required to make it work. Traditional carbon-based methods are relatively slow, necessitating high concentrations that lead directly to the clumping problem. The team led by Professor Jeffrey Bode solved this by introducing boron atoms into carbon-based molecules. This "unnatural" addition creates a coupling reaction that is roughly 1,000 times faster than conventional methods. Consequently, proteins can now be successfully joined at 1,000 times lower concentrations—well below the threshold where clumping occurs.

Developing "Chemical Packaging" for Automated Synthesis

While the potential of boron was identified as early as 2012, the compound was initially too fragile to survive the harsh, acidic conditions found inside automated synthesis robots. It took the Bode group four years of experimentation to find a solution. The eventual breakthrough—discovered by a doctoral student—involved a protective chemical "packaging" that grips the boron group from three sides. This structural reinforcement allows the boron to remain stable during the rigorous protein production process, making the technology compatible with standard laboratory robotics for the first time.